Saccharomyces boulardii in a child with recurrent Clostridium difficile

Pediatrics International

Volumn 51, Issue 1, 2009, Pages 156-158

  Ooi, Chee Y ^a   Dilley, Anthony V ^a   Day, Andrew S ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Clostridium difficile infection; Hirschsprung's disease; Probiotic; Saccharomyces boulardii

Indexed keywords

AMPICILLIN; GENTAMICIN; METRONIDAZOLE; VANCOMYCIN;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; FECES ANALYSIS; GASTROINTESTINAL ENDOSCOPY; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; REHYDRATION; SACCHAROMYCES BOULARDII; TREATMENT OUTCOME;

CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HIRSCHSPRUNG DISEASE; HUMANS; INFANT; MALE; PROBIOTICS; RECURRENCE; SACCHAROMYCES;

EID: 60849093513     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02782.x     Document Type: Article

References (12)

1. Murphy F, Puri P. New insights into the pathogenesis of Hirschsprung's associated enterocolitis. Pediatr. Surg. Int. 2005 21 : 84 9.
2. Tonna I, Welsby PD. Pathogenesis and treatment of Clostridium difficile infection. Postgrad. Med. J. 2005 81 : 367 9.
3. Libby JM, Donta ST, Wilkins TD. Clostridium difficile toxin A in infants. J. Infect. Dis. 1983 48 : 606.
4. Eglow R, Pothoulakis C, Itzkowitz S et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J. Clin. Invest. 1992 90 : 822 9.
5. Maroo S, Lamont JT. Recurrent Clostridium difficile. Gastroenterology 2006 130 : 1311 16.
6. Barbut F, Richard A, Hamadi K et al. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhoea. J. Clin. Microbiol. 2000 36 : 2386 8.
7. Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: A randomized double-blind placebo-controlled trial. Aliment. Pharmacol. Ther. 2005 21 : 583 90.
8. McFarland LV, Surawicz CM, Greenberg RN et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994 271 : 1913 18.
9. Surawicz CM, McFarland LV, Greenberg RN et al. The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis. 2000 31 : 1012 17.
10. Kimmey MB, Elmer GW, Surawicz CM. Prevention of further relapses of Clostridium difficile colitis with Saccharomyces boulardii. Dig. Dis. Sci. 1990 35 : 897 901.
11. Elmer GW, McFarland LV, Surawicz CM et al. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment. Pharmacol. Ther. 1999 13 : 1663 8.
12. Boyle RJ, Robins-Browne RM, Tang MLK. Probiotic use in clinical practice: What are the risks? Am. J. Clin. Nutr. 2006 83 : 1256 64.